GPR39 and depressive disorder: GPR39 deficiency may abolish these monoaminergic-based antidepressant effects since GPR39 KO mice do respond to treatment with the selective serotonin reuptake inhibitor (SSRI), escitalopram, in a forced-swim depression assay [61,102].